Note 9 - Segment Information and Disaggregated Revenue

6 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into two reportable segments as follows: Contract Manufacturing, and Other Nutraceutical Businesses. International sales, concentrated primarily in Europe, for the three months ended December 31, 2022 and 2021 were $1,914 and $2,333, respectively and for the six months ended December 31, 2022 and 2021 were $2,473 and $4,553, respectively.

Financial information relating to the three months ended December 31, 2022 and 2021 operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2022	$	9,768	$	1,914	$	11,682	$	944	$	92	$	32
	2021		11,729		2,333		14,062		1,550		78		177
Other Nutraceutical Businesses	2022		572		-		572		126		1		-
	2021		532		-		532		200		1		-
Total Company	2022		10,340		1,914		12,254		1,070		93		32
	2021		12,261		2,333		14,594		1,750		79		177

Financial information relating to the six months ended December 31, 2022 and 2021 operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2022	$	20,770	$	2,473	$	23,243	$	1,767	$	179	$	82
	2021		21,874		4,523		26,397		2,851		162		308
Other Nutraceutical Businesses	2022		1,337		-		1,337		300		2		-
	2021		918		30		948		323		2		-
Total Company	2022		22,107		2,473		24,580		2,067		181		82
	2021		22,792		4,553		27,345		3,174		164		308

	Total Assets as of
	December 31,		June 30,
	2022		2022
Contract Manufacturing	$	19,880	$	19,061
Other Nutraceutical Businesses		6,172		6,189
Total Company	$	26,052	$	25,250